MOTS-C: Mitochondrial Peptide Research Overview

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. First identified in 2015 by Lee et al. at the University of Southern California, MOTS-C represents a class of mitochondria-derived peptides (MDPs) that act as signalling molecules, influencing cellular metabolism and stress responses. Its mitochondrial origin makes it structurally and functionally distinct from nuclear-encoded peptides.

This article covers the molecular profile and proposed mechanisms of MOTS-C. For a UK research context overview, see: MOTS-C Peptide UK: Research Overview, Laboratory Use & Scientific Context. For a critical appraisal of the evidence base, see: MOTS-C Research: Evidence Quality, Preclinical Data & Scientific Landscape.

All Bloom Vitality products are supplied strictly for in vitro laboratory and research use only.

Molecular Profile

MOTS-C has the amino acid sequence MRWQEMGYIFYPRKLR and a molecular weight of approximately 2.17 kDa. It is encoded by a short open reading frame (sORF) within the 12S rRNA gene of the mitochondrial genome — a highly conserved region across mammalian species. Its mitochondrial encoding is consistent with the hypothesis that mitochondria retain a degree of independent signalling capacity in response to cellular metabolic state.

Proposed Mechanisms

• AMPK pathway activation — MOTS-C is proposed to activate AMP-activated protein kinase (AMPK), a key cellular energy sensor. AMPK activation promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis while inhibiting anabolic processes that consume ATP.
• Folate cycle and methionine metabolism — Research suggests MOTS-C inhibits the folate cycle in the methionine pathway, leading to AICAR accumulation and downstream AMPK activation — providing a mechanistic link between mitochondrial status and nuclear gene expression.
• Insulin sensitisation — Animal studies have demonstrated that MOTS-C administration improves insulin sensitivity and glucose tolerance, particularly in models of diet-induced obesity and age-related metabolic decline.
• Nuclear translocation under stress — Research by Kim et al. (2018) demonstrated that MOTS-C translocates to the nucleus under metabolic stress conditions, where it regulates adaptive nuclear gene expression — a mechanism not previously described for mitochondria-derived peptides.

Areas of Preclinical Research

• Metabolic regulation and insulin sensitivity
• Obesity and diet-induced metabolic dysfunction models
• Age-related metabolic decline
• Exercise performance and skeletal muscle metabolism
• Longevity and healthspan models
• Inflammatory modulation

Research Status

MOTS-C remains at the preclinical stage, with the majority of published research conducted in rodent models. Human data is limited. For a detailed critical appraisal of what is and is not established, see: MOTS-C Research: Evidence Quality, Preclinical Data & Scientific Landscape.

MOTS-C Research Material

Bloom Vitality supplies MOTS-C 40mg as a lyophilised research vial, independently third-party tested for purity and potency. Batch-specific Certificates of Analysis are available via our Certificates & Documentation page and our Testing & Quality page.

Investigators exploring mitochondrial and longevity-related compounds may also be interested in our NAD+ 500mg research material.

For research and laboratory use only. This article is provided for informational purposes and does not constitute medical advice.